Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH)
NCT03735745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2025-01-30
Summary
The purpose of this research study is to see if it is possible to collect tissue, saliva and blood samples from patients who are having surgery and send those samples to different labs across MUSC. The researchers in these labs will collect tissue, blood and saliva samples before surgery and during surgery to see if there are any changes in the samples. They will compare the changes in the samples to the clinical outcomes. Patients will also be given surveys to evaluate patient preferences, anxiety/distress, symptom severity, support by HPV status.
Conditions
Interventions
- OTHER
-
Blood collection
30cc of blood will be collected.
- OTHER
-
Saliva collection
5cc of saliva will be collected.
- OTHER
-
Tissue collection
Up to 10mg of tissue will be collected.
- OTHER
-
Surveys
The Behavioral Risk Factor Surveillance System (BRFSS), Functional Assessment of Cancer Therapy - Head and Neck module (FACT-HN) the Chicago Priority Scale, Cancer Survivor Unmet Needs surveys will be administered at baseline and 3 months post-surgery.
Sponsors & Collaborators
-
Medical University of South Carolina
lead OTHER
Principal Investigators
-
Besim Ogretmen, PhD · Medical University of South Carolina
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-28
- Primary Completion
- 2021-07-15
- Completion
- 2022-07-15
Countries
- United States
Study Locations
More Related Trials
-
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
NCT01312350 ·Status: COMPLETED ·Phase: PHASE2
-
Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma
NCT02892786 ·Status: COMPLETED ·Phase: NA
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
NCT04572100 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)
NCT04696744 ·Status: COMPLETED
-
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
NCT04124198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
NCT01254734 ·Status: TERMINATED ·Phase: NA
-
A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer
NCT02159703 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer
NCT05296135 ·Status: WITHDRAWN
-
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT03010150 ·Status: RECRUITING
-
Cell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380 ·Status: UNKNOWN ·Phase: NA
-
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NCT01473784 ·Status: RECRUITING ·Phase: NA
-
Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer
NCT02079324 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery
NCT06112535 ·Status: COMPLETED ·Phase: NA
-
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
NCT04920344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
NCT05388773 ·Status: RECRUITING ·Phase: PHASE2
-
Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer
NCT05933889 ·Status: RECRUITING
-
Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer
NCT05387915 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
NCT01435252 ·Status: COMPLETED ·Phase: PHASE2
-
Neck Surgery in Treating Patients With Early-Stage Oral Cancer
NCT00571883 ·Status: UNKNOWN ·Phase: NA
-
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
NCT06459180 ·Status: RECRUITING ·Phase: PHASE3
-
TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study
NCT02752932 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer
NCT03107182 ·Status: COMPLETED ·Phase: PHASE2
-
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
NCT07065630 ·Status: RECRUITING ·Phase: PHASE2
-
Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC
NCT04098458 ·Status: COMPLETED ·Phase: NA